SE9900100D0 - New compounds - Google Patents
New compoundsInfo
- Publication number
- SE9900100D0 SE9900100D0 SE9900100A SE9900100A SE9900100D0 SE 9900100 D0 SE9900100 D0 SE 9900100D0 SE 9900100 A SE9900100 A SE 9900100A SE 9900100 A SE9900100 A SE 9900100A SE 9900100 D0 SE9900100 D0 SE 9900100D0
- Authority
- SE
- Sweden
- Prior art keywords
- new compounds
- sub
- compounds
- psychotic
- formula
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Priority Applications (36)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9900100A SE9900100D0 (sv) | 1999-01-15 | 1999-01-15 | New compounds |
CZ20012554A CZ20012554A3 (cs) | 1999-01-15 | 1999-12-23 | Nové aralkylaminy spirofuropyridinů vhodné pro léčení |
ES99967044T ES2200590T3 (es) | 1999-01-15 | 1999-12-23 | Nuevas aralquilaminas de espirofuropiridinas utiles en terapia. |
DK99967044T DK1147114T3 (da) | 1999-01-15 | 1999-12-23 | Hidtil ukendt aralkylaminer af spirofuropyridiner, der er egnede til terapi |
AT99967044T ATE240960T1 (de) | 1999-01-15 | 1999-12-23 | Therapeutisch nützliche arylalkylamine von spirofuropyridinen |
KR1020017008939A KR100660496B1 (ko) | 1999-01-15 | 1999-12-23 | 치료에 유용한 스피로푸로피리딘의 신규 아랄킬 아민 |
EP99967044A EP1147114B1 (en) | 1999-01-15 | 1999-12-23 | Novel aralkyl amines of spirofuropyridines useful in therapy |
UA2001085777A UA71598C2 (en) | 1999-01-15 | 1999-12-23 | Furopiridines aralkilamines, a pharmaceutical composition based thereon, a method for the preparation thereof and furopiridine derivatives |
IL14426699A IL144266A0 (en) | 1999-01-15 | 1999-12-23 | Novel aralkyl amines of spirofuropyridines useful in therapy |
IDW00200101529A ID30034A (id) | 1999-01-15 | 1999-12-23 | Aralkil amina baru dari spirofuropiridin yang berguna dalam terapi |
TR2001/02042T TR200102042T2 (tr) | 1999-01-15 | 1999-12-23 | Spiro fropiridinlerin, tedavide faydalı yeni aralkil aminleri. |
EEP200100370A EE04528B1 (et) | 1999-01-15 | 1999-12-23 | Teraapias kasutatavad spirofuropridiinide aralklamiinid |
US09/529,654 US6995167B2 (en) | 1999-01-15 | 1999-12-23 | Arylkylamine spirofuropyridines useful in therapy |
AU23343/00A AU775433B2 (en) | 1999-01-15 | 1999-12-23 | Novel aralkyl amines of spirofuropyridines useful in therapy |
HU0200513A HUP0200513A3 (en) | 1999-01-15 | 1999-12-23 | Novel aralkyl amines of spirofuropyridines useful in therapy, process for their preparation, pharmaceutical compositions containing them and their use |
DE69908185T DE69908185T2 (de) | 1999-01-15 | 1999-12-23 | Therapeutisch nützliche arylalkylamine von spirofuropyridinen |
SK993-2001A SK9932001A3 (en) | 1999-01-15 | 1999-12-23 | Novel aralkyl amines of spirofuropyridines useful in therapy |
NZ512733A NZ512733A (en) | 1999-01-15 | 1999-12-23 | Aralkyl amines of spirofuropyridines useful in treating psychotic and intellectual impairment disorders |
PT99967044T PT1147114E (pt) | 1999-01-15 | 1999-12-23 | Novos aralquilaminas de espirofuropiridinas uteis em terapia. |
SI9930375T SI1147114T1 (en) | 1999-01-15 | 1999-12-23 | Novel aralkyl amines of spirofuropyridines useful in therapy |
JP2000593611A JP2002534525A (ja) | 1999-01-15 | 1999-12-23 | 治療において有用なスピロフロピリジンの新規なアラルキルアミン |
CA002359990A CA2359990A1 (en) | 1999-01-15 | 1999-12-23 | Novel aralkyl amines of spirofuropyridines useful in therapy |
CN998164224A CN1132837C (zh) | 1999-01-15 | 1999-12-23 | 螺呋喃并吡啶芳烷基胺、其制法和中间体及其药物组合物和制药用途 |
PCT/SE1999/002478 WO2000042044A1 (en) | 1999-01-15 | 1999-12-23 | Novel aralkyl amines of spirofuropyridines useful in therapy |
RU2001122812/04A RU2233282C2 (ru) | 1999-01-15 | 1999-12-23 | Аралкиламины фуропиридинов, способ их получения, фармацевтическая композиция на их основе и промежуточные вещества |
BR9916906-1A BR9916906A (pt) | 1999-01-15 | 1999-12-23 | Composto, composição farmacêutica, uso de umcomposto, métodos de tratamento ou profilaxiade, distúrbios psicóticos ou distúrbios deenfraquecimento intelectual, e de tratamento ouprofilaxia de doenças ou condições humanas emque a ativação do receptor alfa-7 nicotìnico ébenéfica, e, processo para preparar um composto |
ARP000100156A AR022283A1 (es) | 1999-01-15 | 2000-01-13 | Aminas substituidas de espirofuropiridinas novedosas utiles en terapia |
MYPI20000100A MY118109A (en) | 1999-01-15 | 2000-01-13 | Novel aralkyl amines of spirofuropyridines useful in therapy |
TW089100989A TWI227237B (en) | 1999-01-15 | 2000-01-21 | Novel aralkyl amines of spirofuropyridines useful in therapy |
TW093106537A TW200413387A (en) | 1999-01-15 | 2000-01-21 | Novel intermediates for preparing aralkyl amines of spirofuropyridines useful in therapy |
SA00200987A SA00200987B1 (ar) | 1999-01-15 | 2000-02-21 | Aralkyl Amines جديدة من Spirofuropyridines مفيدة في العلاج |
ZA200105527A ZA200105527B (en) | 1999-01-15 | 2001-07-04 | Novel aralkyl amines of spirofuropyridines useful in therapy. |
IS6000A IS6000A (is) | 1999-01-15 | 2001-07-12 | Ný aralkýlamín af spírófúrópýridínum sem nytsamleg eru í meðferð |
NO20013478A NO20013478L (no) | 1999-01-15 | 2001-07-13 | Nye aralkylaminer av spirofuropyridiner som er nyttige i terapi |
HK02102161.7A HK1040517B (zh) | 1999-01-15 | 2002-03-21 | 治療中有用的新的螺呋喃並吡啶芳烷基胺 |
US11/181,098 US7196096B2 (en) | 1999-01-15 | 2005-07-14 | Substituted amines of spirofuropyridines useful in therapy |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9900100A SE9900100D0 (sv) | 1999-01-15 | 1999-01-15 | New compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
SE9900100D0 true SE9900100D0 (sv) | 1999-01-15 |
Family
ID=20414101
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE9900100A SE9900100D0 (sv) | 1999-01-15 | 1999-01-15 | New compounds |
Country Status (34)
Country | Link |
---|---|
US (2) | US6995167B2 (sv) |
EP (1) | EP1147114B1 (sv) |
JP (1) | JP2002534525A (sv) |
KR (1) | KR100660496B1 (sv) |
CN (1) | CN1132837C (sv) |
AR (1) | AR022283A1 (sv) |
AT (1) | ATE240960T1 (sv) |
AU (1) | AU775433B2 (sv) |
BR (1) | BR9916906A (sv) |
CA (1) | CA2359990A1 (sv) |
CZ (1) | CZ20012554A3 (sv) |
DE (1) | DE69908185T2 (sv) |
DK (1) | DK1147114T3 (sv) |
EE (1) | EE04528B1 (sv) |
ES (1) | ES2200590T3 (sv) |
HK (1) | HK1040517B (sv) |
HU (1) | HUP0200513A3 (sv) |
ID (1) | ID30034A (sv) |
IL (1) | IL144266A0 (sv) |
IS (1) | IS6000A (sv) |
MY (1) | MY118109A (sv) |
NO (1) | NO20013478L (sv) |
NZ (1) | NZ512733A (sv) |
PT (1) | PT1147114E (sv) |
RU (1) | RU2233282C2 (sv) |
SA (1) | SA00200987B1 (sv) |
SE (1) | SE9900100D0 (sv) |
SI (1) | SI1147114T1 (sv) |
SK (1) | SK9932001A3 (sv) |
TR (1) | TR200102042T2 (sv) |
TW (2) | TW200413387A (sv) |
UA (1) | UA71598C2 (sv) |
WO (1) | WO2000042044A1 (sv) |
ZA (1) | ZA200105527B (sv) |
Families Citing this family (55)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE9900100D0 (sv) | 1999-01-15 | 1999-01-15 | Astra Ab | New compounds |
FR2790474B1 (fr) * | 1999-03-05 | 2001-04-06 | Synthelabo | Derives de pyridopyranoazepines, leur preparation et leur application en therapeutique |
NZ529426A (en) * | 2001-06-01 | 2005-07-29 | Astrazeneca Ab | Spiroazabicyclic heterocyclic amine ligands for nicotinic acetylcholine receptors useful in therapy |
US6569865B2 (en) | 2001-06-01 | 2003-05-27 | Astrazeneca Ab | Spiro 1-azabicyclo[2.2.2]octane-3,2′(3′h)-furo[2,3-b]pyridine |
NZ531786A (en) | 2001-10-02 | 2006-10-27 | Upjohn Co | Azabicyclic-substituted fused-heteroaryl compounds for the treatment of disease |
DE10164139A1 (de) | 2001-12-27 | 2003-07-10 | Bayer Ag | 2-Heteroarylcarbonsäureamide |
KR20040099447A (ko) * | 2002-04-18 | 2004-11-26 | 아스트라제네카 아베 | 푸릴 화합물 |
KR20040099446A (ko) * | 2002-04-18 | 2004-11-26 | 아스트라제네카 아베 | 헤테로시클릭 화합물 |
DE60333746D1 (de) * | 2002-04-18 | 2010-09-23 | Astrazeneca Ab | Thienylverbindungen |
EP2305664A1 (en) | 2002-08-30 | 2011-04-06 | Memory Pharmaceuticals Corporation | Anabaseine derivatives useful in the treatment of neurodegeneratives diseases |
SE0202598D0 (sv) * | 2002-09-02 | 2002-09-02 | Astrazeneca Ab | Alpha-7 Nicotinic receptor agonists and statins in combination |
GB0220581D0 (en) | 2002-09-04 | 2002-10-09 | Novartis Ag | Organic Compound |
BR0314485A (pt) | 2002-09-25 | 2005-07-26 | Memory Pharm Corp | Indazóis, benzotiazóis e benzoisotiazóis, composto, composição farmacêutica, método desativação/estimulação seletiva de receptores nicotìnicos de a-7 em um mamìfero e método de tratamento e/ou prevenção de uma doença com os mesmos |
EP2062595A1 (en) * | 2002-12-06 | 2009-05-27 | The Feinstein Institute for Medical Research | Inhibition of inflammation using alpha 7 receptor-binding cholinergic agonists |
US7238715B2 (en) * | 2002-12-06 | 2007-07-03 | The Feinstein Institute For Medical Research | Treatment of pancreatitis using alpha 7 receptor-binding cholinergic agonists |
KR101063605B1 (ko) * | 2003-01-08 | 2011-09-07 | 미쓰비시 타나베 파마 코퍼레이션 | 정신분열증 치료제 |
WO2005000250A2 (en) * | 2003-06-24 | 2005-01-06 | Johns Hopkins University | Imaging agents and methods of imaging alpha 7-nicotinic cholinergic receptor |
MXPA06004299A (es) * | 2003-10-21 | 2006-06-05 | Astrazeneca Ab | Derivados de arilespirofuropiridina. |
US7045530B2 (en) | 2003-12-22 | 2006-05-16 | Abbott Laboratories | Spirocyclic quinuclidinic ether derivatives |
WO2005092890A2 (en) | 2004-03-25 | 2005-10-06 | Memory Pharmaceuticals Corporation | Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, and preparation and uses thereof |
PE20060437A1 (es) | 2004-06-18 | 2006-06-08 | Novartis Ag | COMPUESTOS AZA-BICICLONONANOS COMO LIGANDOS COLINERGICOS DE nAChR |
GB0415746D0 (en) | 2004-07-14 | 2004-08-18 | Novartis Ag | Organic compounds |
GB0521508D0 (en) | 2005-10-21 | 2005-11-30 | Novartis Ag | Organic compounds |
US8316104B2 (en) | 2005-11-15 | 2012-11-20 | California Institute Of Technology | Method and apparatus for collaborative system |
GB0525672D0 (en) | 2005-12-16 | 2006-01-25 | Novartis Ag | Organic compounds |
GB0525673D0 (en) | 2005-12-16 | 2006-01-25 | Novartis Ag | Organic compounds |
RU2448111C2 (ru) * | 2006-08-21 | 2012-04-20 | Дженентек, Инк. | Соединения азабензофуранила и способ их применения |
CL2008000119A1 (es) | 2007-01-16 | 2008-05-16 | Wyeth Corp | Compuestos derivados de pirazol, antagonistas del receptor nicotinico de acetilcolina; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como demencia senil, alzheimer y esquizofrenia. |
SA08290475B1 (ar) | 2007-08-02 | 2013-06-22 | Targacept Inc | (2s، 3r)-n-(2-((3-بيردينيل)ميثيل)-1-آزا بيسيكلو[2، 2، 2]أوكت-3-يل)بنزو فيوران-2-كربوكساميد، وصور أملاحه الجديدة وطرق استخدامه |
NZ590616A (en) | 2008-06-20 | 2012-09-28 | Astrazeneca Ab | Dibenzothiazepine derivatives and use thereof |
RU2011119626A (ru) | 2008-10-17 | 2012-11-27 | Ксенон Фармасьютикалз Инк. | Спирооксиндольные соединения и их применение в качестве терапевтичеких средств |
PT2540297E (pt) | 2008-11-19 | 2015-08-26 | Forum Pharmaceuticals Inc | Tratamento de distúrbios cognitivos com (r)-7-cloro-n- (quinuclidin-3-il)benzo[b]tiofeno-2-carboxamida e sais farmaceuticamente aceitáveis desta |
TW201031664A (en) | 2009-01-26 | 2010-09-01 | Targacept Inc | Preparation and therapeutic applications of (2S,3R)-N-2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)-3,5-difluorobenzamide |
AU2010247835A1 (en) * | 2009-05-11 | 2011-12-08 | Envivo Pharmaceuticals, Inc. | Treatment of cognitive disorders with certain alpha-7 nicotinic acid receptors in combination with acetylcholinesterase inhibitors |
AR077252A1 (es) | 2009-06-29 | 2011-08-10 | Xenon Pharmaceuticals Inc | Enantiomeros de compuestos de espirooxindol y sus usos como agentes terapeuticos |
RU2015103694A (ru) * | 2009-10-14 | 2015-06-27 | Ксенон Фармасьютикалз Инк. | Способы синтеза спиро-оксиндольных соединений |
CN102946859B (zh) | 2010-02-26 | 2016-03-02 | 泽农医药公司 | 用于局部给药的螺-羟吲哚化合物的药物组合物及其作为治疗剂的用途 |
SA111320455B1 (ar) | 2010-05-17 | 2014-10-16 | Envivo Pharmaceuticals Inc | صورة بلورية من (R)-7- كلورو -N- (كينوكليدين -3- يل) بنزو[b] ثيوفين -2- كربوكساميد هيدروكلوريد أحادي الهيدرات |
GB201111704D0 (en) | 2011-07-07 | 2011-08-24 | Takeda Pharmaceutical | Novel compounds |
GB201111705D0 (en) | 2011-07-07 | 2011-08-24 | Takeda Pharmaceutical | Compounds and their use |
JO3115B1 (ar) | 2011-08-22 | 2017-09-20 | Takeda Pharmaceuticals Co | مركبات بيريدازينون واستخدامها كمثبطات daao |
JP6195609B2 (ja) | 2012-04-12 | 2017-09-13 | ゼノン・ファーマシューティカルズ・インコーポレイテッドXenon Pharmaceuticals Inc. | 治療剤として有用なスピロ−オキソインドール化合物の不斉合成 |
EP3666272A1 (en) | 2012-05-08 | 2020-06-17 | Forum Pharmaceuticals Inc. | Use of encenicline in the treatment of cognitive impairment, alzheimer's disease, memory deficit |
GB201209587D0 (en) | 2012-05-30 | 2012-07-11 | Takeda Pharmaceutical | Therapeutic compounds |
US9593106B2 (en) | 2013-02-07 | 2017-03-14 | Heptares Therapeutics Limited | Piperidin-1-yl and azepin-1-yl carboxylates as muscarinic M4 receptor agonists |
CN105324372B (zh) | 2013-06-21 | 2018-03-06 | 武田药品工业株式会社 | 作为前动力蛋白受体调节剂的1‑磺酰基哌啶衍生物 |
GB201314286D0 (en) | 2013-08-08 | 2013-09-25 | Takeda Pharmaceutical | Therapeutic Compounds |
GB201318222D0 (en) | 2013-10-15 | 2013-11-27 | Takeda Pharmaceutical | Novel compounds |
GB201320905D0 (en) | 2013-11-27 | 2014-01-08 | Takeda Pharmaceutical | Therapeutic compounds |
TW201613864A (en) | 2014-02-20 | 2016-04-16 | Takeda Pharmaceutical | Novel compounds |
TW201636017A (zh) | 2015-02-05 | 2016-10-16 | 梯瓦製藥國際有限責任公司 | 以螺吲哚酮化合物之局部調配物治療帶狀疱疹後遺神經痛之方法 |
WO2017218920A1 (en) | 2016-06-16 | 2017-12-21 | Teva Pharmaceuticals International Gmbh | Asymmetric synthesis of funapide |
GB201616839D0 (en) | 2016-10-04 | 2016-11-16 | Takeda Pharmaceutical Company Limited | Therapeutic compounds |
GB201619514D0 (en) | 2016-11-18 | 2017-01-04 | Takeda Pharmaceuticals Co | Novel compounds |
JP2021138648A (ja) | 2020-03-04 | 2021-09-16 | 武田薬品工業株式会社 | 経口固形製剤 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3853758T2 (de) * | 1987-10-05 | 1995-09-07 | Yamanouchi Pharma Co Ltd | Heterozyklische Spiroverbindungen und ihre Herstellung. |
JPH0195922A (ja) | 1987-10-08 | 1989-04-14 | Mazda Motor Corp | 車両のサスペンション制御装置 |
RU2148058C1 (ru) * | 1994-08-24 | 2000-04-27 | Астра Актиеболаг | Спиро-азабициклические соединения, способы их получения и промежуточные продукты |
JP4176147B2 (ja) * | 1995-07-28 | 2008-11-05 | アボツト・ラボラトリーズ | 化学的シナプス伝達の制御に有用なフロピリジン、チエノピリジン、ピロロピリジンおよび関連するピリミジン、ピリダジンおよびトリアジン化合物 |
US6156783A (en) | 1996-04-30 | 2000-12-05 | Smithkline Beecham P.L.C. | Spiroazabicyclic compounds, processes for their preparation, and their pharmaceutical use |
AR013184A1 (es) * | 1997-07-18 | 2000-12-13 | Astrazeneca Ab | Aminas heterociclicas espiroazobiciclicas, composicion farmaceutica, uso de dichas aminas para preparar medicamentos y metodo de tratamiento o profilaxis |
SE9900100D0 (sv) | 1999-01-15 | 1999-01-15 | Astra Ab | New compounds |
-
1999
- 1999-01-15 SE SE9900100A patent/SE9900100D0/sv unknown
- 1999-12-23 US US09/529,654 patent/US6995167B2/en not_active Expired - Fee Related
- 1999-12-23 SK SK993-2001A patent/SK9932001A3/sk unknown
- 1999-12-23 CZ CZ20012554A patent/CZ20012554A3/cs unknown
- 1999-12-23 DE DE69908185T patent/DE69908185T2/de not_active Expired - Fee Related
- 1999-12-23 DK DK99967044T patent/DK1147114T3/da active
- 1999-12-23 TR TR2001/02042T patent/TR200102042T2/xx unknown
- 1999-12-23 EP EP99967044A patent/EP1147114B1/en not_active Expired - Lifetime
- 1999-12-23 AT AT99967044T patent/ATE240960T1/de not_active IP Right Cessation
- 1999-12-23 CA CA002359990A patent/CA2359990A1/en not_active Abandoned
- 1999-12-23 JP JP2000593611A patent/JP2002534525A/ja active Pending
- 1999-12-23 PT PT99967044T patent/PT1147114E/pt unknown
- 1999-12-23 UA UA2001085777A patent/UA71598C2/uk unknown
- 1999-12-23 ES ES99967044T patent/ES2200590T3/es not_active Expired - Lifetime
- 1999-12-23 SI SI9930375T patent/SI1147114T1/xx unknown
- 1999-12-23 KR KR1020017008939A patent/KR100660496B1/ko not_active IP Right Cessation
- 1999-12-23 IL IL14426699A patent/IL144266A0/xx unknown
- 1999-12-23 AU AU23343/00A patent/AU775433B2/en not_active Ceased
- 1999-12-23 HU HU0200513A patent/HUP0200513A3/hu unknown
- 1999-12-23 ID IDW00200101529A patent/ID30034A/id unknown
- 1999-12-23 NZ NZ512733A patent/NZ512733A/en unknown
- 1999-12-23 RU RU2001122812/04A patent/RU2233282C2/ru not_active IP Right Cessation
- 1999-12-23 BR BR9916906-1A patent/BR9916906A/pt not_active Application Discontinuation
- 1999-12-23 EE EEP200100370A patent/EE04528B1/xx not_active IP Right Cessation
- 1999-12-23 WO PCT/SE1999/002478 patent/WO2000042044A1/en active IP Right Grant
- 1999-12-23 CN CN998164224A patent/CN1132837C/zh not_active Expired - Fee Related
-
2000
- 2000-01-13 MY MYPI20000100A patent/MY118109A/en unknown
- 2000-01-13 AR ARP000100156A patent/AR022283A1/es not_active Application Discontinuation
- 2000-01-21 TW TW093106537A patent/TW200413387A/zh unknown
- 2000-01-21 TW TW089100989A patent/TWI227237B/zh not_active IP Right Cessation
- 2000-02-21 SA SA00200987A patent/SA00200987B1/ar unknown
-
2001
- 2001-07-04 ZA ZA200105527A patent/ZA200105527B/en unknown
- 2001-07-12 IS IS6000A patent/IS6000A/is unknown
- 2001-07-13 NO NO20013478A patent/NO20013478L/no not_active Application Discontinuation
-
2002
- 2002-03-21 HK HK02102161.7A patent/HK1040517B/zh not_active IP Right Cessation
-
2005
- 2005-07-14 US US11/181,098 patent/US7196096B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE9900100D0 (sv) | New compounds | |
SE9903760D0 (sv) | New compounds | |
GB9801690D0 (en) | Therapeutic agents | |
DE60112974D1 (en) | Carbolinderivate | |
HK1086256A1 (en) | Substituted pyrrolo-pyrazole derivatives as kinase inhibitors | |
DK1112106T3 (da) | Serotonerge 5HT2-agonister til behandling af glaukom | |
SE9904176D0 (sv) | New use | |
ATE305788T1 (de) | (s,s)-reboxetin zur behandlung von inkontinenz | |
HK1155146A1 (zh) | 作為藥物活性劑的茚衍生物 | |
GB9929552D0 (en) | Compounds | |
DE60216233D1 (en) | Carbolinderivate | |
MXPA03002911A (es) | Compuestos quimicos. | |
AU2001266575A1 (en) | Chemical compounds | |
MXPA02012076A (es) | Compuestos quimicos. | |
PE20030061A1 (es) | 1-biaril-1,8-naftiridin-4-ona como inhibidores de fosfodiesterasa-4 | |
GB0114185D0 (en) | Compounds | |
WO2002070469A3 (en) | Selective pde3b inhibitors and use of the same in therapy | |
BR0017157A (pt) | Derivados de 6-hidroxi-indazol para o tratamento de glaucoma | |
SE9904765D0 (sv) | Pharmaceutically-useful compounds | |
TR200201128T2 (tr) | PDE4 inhibitörleri olarak tetrahidrotiyopiranfitalazinon türevleri. | |
SE0003476D0 (sv) | Compounds | |
ATE417856T1 (de) | Motilidverbindungen | |
DE60112960D1 (de) | Kondensierte pyridoindolderivate | |
CA2412596A1 (en) | Cyclic gmp-specific phosphodiesterase inhibitors | |
PT1204659E (pt) | Benzofuranos serotoninergicos |